| Jun 5 2020 |
Proposed California Legislation Would Require State Approval for Health Care M&A and Prohibit Use of Health Care Market Power to Raise Price |
Polsinelli PC |
| Jun 5 2020 |
NOL Carryback Rule Changes Bring Benefits For M&A Parties |
Polsinelli PC |
| Jun 5 2020 |
Polish Government to Adopt Stricter Control over Private Investments |
Squire Patton Boggs (US) LLP |
| Jun 4 2020 |
CA SB 977 Would Expand AG Review Of Healthcare Transactions |
McDermott Will & Emery |
| Jun 4 2020 |
Dutch Court Decisions on Contractual Obligations During the COVID-19 Pandemic in an M&A Context |
Greenberg Traurig, LLP |
| Jun 4 2020 |
Pre-merger Control Filing in China Concerning Variable Interest Entity Structures |
K&L Gates LLP |
| Jun 2 2020 |
Merger Transactions Reported to FTC, DOJ Reach 10-Year High |
Cornerstone Research |
| Jun 2 2020 |
CFIUS Clearance: Huatai Securities, AssetMark Financial Holdings and WBI OBS Financial |
Squire Patton Boggs (US) LLP |
| Jun 2 2020 |
A Comparison of the US Draft Vertical Merger Guidelines with the EU Non-Horizontal and the UK Merger Assessment Guidelines |
Cornerstone Research |
| May 28 2020 |
Dining Delivery Disruptors Disrupted: DOJ, FTC Should Examine Uber’s Planned Purchase of Grubhub, Senators Say |
MoginRubin |
| May 22 2020 |
Top Takeaways: Critical Business Considerations for Life Sciences and Medical Device Companies During COVID-19 |
McDermott Will & Emery |
| May 22 2020 |
Top Takeaways: Permissible Provider Collaborations During COVID-19 and Beyond |
McDermott Will & Emery |
| May 20 2020 |
And Now for Something Completely Different – EU Abuse Principles Sink Self-Serving Contract Variation |
Squire Patton Boggs (US) LLP |
| May 19 2020 |
End of an Era: The U.S. is No Longer the Authority Figure for Multinational Mergers |
MoginRubin |
| May 13 2020 |
COVID-19 and Material Adverse Effect in M&A Transactions |
Womble Bond Dickinson (US) LLP |
| May 12 2020 |
CARES Act: Impact of revised net operating loss rules in M&A transactions |
Godfrey & Kahn S.C. |
| May 8 2020 |
A Secret They Don’t Want to Keep: Buyer Sought to Terminate Deal for Victoria’s Secret |
Godfrey & Kahn S.C. |
| May 7 2020 |
Does the Coronavirus Change the Material Adverse Event Clause for Mergers & Acquisitions? |
Mintz |
| May 7 2020 |
COVID-19 Update: Antitrust Enforcement Remains Robust Despite COVID-19 |
Cadwalader, Wickersham & Taft LLP |
| May 6 2020 |
Energy & Sustainability M&A Activity – May 2020 |
Mintz |
| May 5 2020 |
COVID-19: Distressed M&A in the Era of a Pandemic |
K&L Gates LLP |
| May 4 2020 |
Recent Decision in Newmont Mining Reinforces the High Bar Buyers Face when Attempting to Establish a Material Adverse Event |
Mintz |
| Apr 30 2020 |
COVID-19 and Poison Pills: The Right Prescription? |
Mintz |
| Apr 30 2020 |
COVID-19: Proposed Legislation Would Prohibit Many Mergers and Acquisitions During Pandemic |
K&L Gates LLP |
| Apr 30 2020 |
Court of Chancery Applies Entire Fairness Standard to PennyMac’s Reorganization Transaction |
K&L Gates LLP |
| Apr 29 2020 |
How Antitrust Will Shape M&A During the Pandemic |
Foley & Lardner LLP |
| Apr 29 2020 |
COVID-19 Impacts on the Copyright Office: What Does It Mean for Mergers and Acquisitions? |
Faegre Drinker |
| Apr 27 2020 |
Is a Moratorium on Mergers During the Pandemic a Bridge Too Far? |
MoginRubin |
| Apr 24 2020 |
M&A in the Investment Services Space – Help! My Deal Went Sideways… |
Norris McLaughlin P.A. |
| Apr 22 2020 |
In Application of American Express to Horizontal Merger Challenge, District Court Allows Merger of Airline Ticket Platforms |
Mintz |
| Apr 22 2020 |
United Technologies/Raytheon Highlights Key Issues in Aerospace and Defense Industry Merger Review |
McDermott Will & Emery |
| Apr 21 2020 |
Poison Pills, NOL Poison Pills and the COVID-19 Pandemic |
Robinson & Cole LLP |
| Apr 16 2020 |
Revisiting Guidance on MFN Terms |
Cornerstone Research |
| Apr 16 2020 |
Force Majeure and Frustration in English Law M&A Agreements in the Context of COVID-19 |
Katten |
| Apr 15 2020 |
How Will COVID-19 Impact M&A? |
Robinson & Cole LLP |
